ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Pivotal time for CROs': ICON CEO Cutler on changing APAC trial trends
Steve Cutler and Atsushi Ogawa discuss the increased opportunity for decentralised trials, in addition to the challenges and opportunities in Asia Pacific.
This article reflects on the progress that has been made in decentralised and hybrid clinical trials in the last number of years.
Historical Controls in Rare Disease drug development: Using RWE to overcome key challenges
This article explores the advantages of using Historical Controls, as well as several considerations for their effective use.
Fortifying vaccines through disease surveillance and data reporting
In this article, McLendon explores the topic of fortifying vaccines against future pandemics.
The power of partnership: Collaborating with patient advocacy organisations for better clinical research
Laura Iliescu explores the powerful potential of collaboration with PAOs for clinical trials, how PAOs can inform trial design and the creation of patient registries.
Improving early phase oncology clinical trial design: An opportunity for statisticians
In this article, our experts offer their insights on the use of rule-based study designs in early phase oncology development programs.
Life sciences sector remains strong in Ireland despite challenges
Brendan Brennan outlines the importance of collaboration between industry and academia in this article from the Irish Times Life Sciences special report.
Turning an ocean of data into actionable wisdom to support optimal site identification
Travis Caudill, VP Feasibility & Clinical Informatics, offers his insights on how advancements in AI can help the pharmaceutical industry identify the best sites for their clinical trials through the harnessing of Big Data.
Ensuring success in pharmacovigilance and patient safety
This article explores opportunities for outsourcing pharmacovigilance services, potential models, and best practices for selecting a service provider.
Life sciences industry an active player in pandemic response
Rose Kidd outlines the role ICON played in the global response to the COVID-19 pandemic in the Irish Times Life Sciences special report.